Skip to content

Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles

A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of Sculptra Aesthetic for Correction of Cheek Wrinkles.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04124692
Enrollment
149
Registered
2019-10-11
Start date
2019-11-12
Completion date
2021-08-12
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cheek Wrinkles

Brief summary

The study has been designed to evaluate the safety and effectiveness of Sculptra Aesthetic as a single regimen for correction of cheek wrinkles after changes in reconstitution and injection procedures compared to the approved label.

Interventions

DEVICESculptra Aesthetic new dilution

Treatment of cheek wrinkles

Sponsors

Galderma R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Intent to undergo correction of cheek wrinkles on both sides of the face and a Galderma Cheek Wrinkles Scale (GCWS) At Rest score of Moderate or Severe on EACH side of the face.

Exclusion criteria

* Known/previous allergy or hypersensitivity to any of the Sculptra Aesthetic constituents. * Previous tissue augmenting therapy, contouring or revitalization treatment in the face, except the lips, with any of the following fillers prior to Baseline visit: 1. Collagen, Hyaluronic Acid - 12 months 2. Calcium Hydroxyapatite (CaHa), Poly L- Lactic Acid (PLLA) or permanent (nonbiodegradable)- Prohibited

Design outcomes

Primary

MeasureTime frameDescription
Responder Rate Based on the Blinded Evaluator's Live Assessment of the Galderma Cheek Wrinkles Scale (GCWS) at Rest at Month 12At Month 12Responder rate was defined as the percentage of participants with at least a 1-grade improvement from baseline on the GCWS, on both sides of the face, concurrently. GCWS is a validated 5-point scale used to assess the severity of cheek wrinkles: 0 (none \[no lines or wrinkles\]), 1 (mild \[only few superficial lines\]), 2 (moderate \[many superficial lines or a few shallow wrinkles\]), 3 (severe \[many shallow wrinkles or a few moderate depth wrinkles\]) and 4 (very severe \[many moderate wrinkles or at least one depth wrinkle with or without redundant folds\]). Higher score means more severe (worse) wrinkles. The participant was to have a relaxed face during the assessment.

Secondary

MeasureTime frameDescription
Responder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12At Months 7, 9, and 12Responder rate was defined as the percentage of participants with at least a 1-grade improvement from baseline on the GCWS, on both sides of the face, concurrently. GCWS is a validated 5-point scale used to assess the severity of cheek wrinkles: 0 (none \[no lines or wrinkles\]), 1 (mild \[only few superficial lines\]), 2 (moderate \[many superficial lines or a few shallow wrinkles\]), 3 (severe \[many shallow wrinkles or a few moderate depth wrinkles\]) and 4 (very severe \[many moderate wrinkles or at least one depth wrinkle with or without redundant folds\]). Higher score means more severe (worse) wrinkles. The participant was to have a closed maximum smile during the assessment.
Percentage of Participants With Improvement Rate Based on the Independent Photographic Reviewer's AssessmentAt Month 12Improvement rate based on the Independent Photographic Reviewer's assessment using random pairings of baseline and Month 12 photographs was done. An improved subject is defined as a subject for whom the Independent Photographic Reviewer identified the month 12 photograph in the pair as post-treatment.
Percentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentAt Months 7, 9, and 12GAIS responder rates are based on independent assessments by the participant. Responder rate was defined as the percentage of participants with at least Improved when compared to baseline before first treatment. The 7-graded GAIS was used by the participant to live assess the aesthetic improvement of the cheek wrinkles by responding to the question: How would you describe the aesthetic improvement today compared to the photograph taken before treatment? by using the respective categorical scale as follows; Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse.
Percentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentAt Months 7, 9, and 12GAIS responder rates are based on independent assessments by the investigator. Responder rate was defined as the percentage of participants with at least Improved when compared to baseline before first treatment. The 7-graded GAIS was used by the investigator to live assess the aesthetic improvement of the cheek wrinkles by responding to the question: How would you describe the aesthetic improvement today compared to the photograph taken before treatment? by using the respective categorical scale as follows; Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse.
Satisfaction With Treatment: Does the Treatment Make You Look Younger?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Responder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS at Rest at Months 7 and 9At Months 7 and 9Responder rate was defined as the percentage of participants with at least a 1-grade improvement from baseline on the GCWS, on both sides of the face, concurrently. GCWS is a validated 5-point scale used to assess the severity of cheek wrinkles: 0 (none \[no lines or wrinkles\]), 1 (mild \[only few superficial lines\]), 2 (moderate \[many superficial lines or a few shallow wrinkles\]), 3 (severe \[many shallow wrinkles or a few moderate depth wrinkles\]) and 4 (very severe \[many moderate wrinkles or at least one depth wrinkle with or without redundant folds\]). Higher score means more severe (worse) wrinkles. The participant was to have a relaxed face during the assessment.
Satisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Satisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.
Subject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Strongly agree, Agree, Neither agree or Disagree, Disagree, Strongly disagree.
Subject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Strongly agree, Agree, Neither agree or Disagree, Disagree, Strongly disagree.
Subject Satisfaction: Would You Recommend the Treatment to a Friend?At Month 12A subject satisfaction question with responses Yes or No.
Subject Satisfaction: Would You do the Treatment Again?At Month 12A subject satisfaction question with responses Yes or No.
Change From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresTreatment group: Baseline, Months 1, 2, 3, 7, 9 and 12; Control group: Baseline, Months 7, 9 and 12The participant assessed satisfaction using the 5 questions on the FACE-Q: Satisfaction with Cheeks Appearance questionnaire measured on a 4-point scale where 1=very dissatisfied, 2=somewhat dissatisfied, 3=somewhat satisfied, and 4=very satisfied. The responses to the items were converted to a 100-point Rasch transformed total score with 0 (worst) to 100 (best). Higher scores indicate higher satisfaction. A negative change from baseline indicates less improvement.
Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEsFrom start of study drug administration up to end of the study (up to Month 12)An adverse event (AE) was any untoward medical occurrence in a clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. TEAEs were defined as AEs with a start date on or after the first dose of investigational product or a start date before the date of the first dose of investigational product that increased in severity or after the date of the first dose. A SAE was any untoward medical occurrence (whether considered to be related to investigational product or not) that at any dose: resulted in death, was life-threatening, required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, was a congenital abnormality/birth defect, and was an important medical event. TEAEs included both serious and non-serious TEAEs.
Satisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Months 7, 9, and 12A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Countries

United States

Participant flow

Recruitment details

The study was conducted at 13 sites at the United States from 12 November 2019 to12 August 2021.

Pre-assignment details

A total of 149 participants were enrolled and randomized, of which 97 received treatment and 52 received no treatment in this study.

Participants by arm

ArmCount
Control Group: No-treatment
Participants received no treatment during the study.
52
Treatment Group: Sculptra Aesthetic
Participants were injected with Sculptra Aesthetic by treating investigator at Day 1 until optimal correction achieved (up to 4 total treatment sessions).
97
Total149

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up24
Overall StudyMedical reason01
Overall StudyScreen failure due to previous use of Radiesse10
Overall StudyWithdrawal of informed consent (due to coronavirus disease-19 concerns)13
Overall StudyWithdrawal of informed consent (not due to coronavirus disease-19 concerns)21

Baseline characteristics

CharacteristicTotalTreatment Group: Sculptra AestheticControl Group: No-treatment
Age, Continuous60.7 years
STANDARD_DEVIATION 8.55
60.9 years
STANDARD_DEVIATION 8.5
60.4 years
STANDARD_DEVIATION 8.72
Ethnicity (NIH/OMB)
Hispanic or Latino
137 Participants90 Participants47 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants7 Participants5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Fitzpatrick Skin Type score (FST)
FST I
6 Participants4 Participants2 Participants
Fitzpatrick Skin Type score (FST)
FST II
43 Participants25 Participants18 Participants
Fitzpatrick Skin Type score (FST)
FST III
68 Participants47 Participants21 Participants
Fitzpatrick Skin Type score (FST)
FST IV
18 Participants12 Participants6 Participants
Fitzpatrick Skin Type score (FST)
FST V
9 Participants5 Participants4 Participants
Fitzpatrick Skin Type score (FST)
FST VI
5 Participants4 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
11 Participants7 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
135 Participants88 Participants47 Participants
Sex: Female, Male
Female
144 Participants94 Participants50 Participants
Sex: Female, Male
Male
5 Participants3 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 520 / 97
other
Total, other adverse events
0 / 5211 / 97
serious
Total, serious adverse events
0 / 523 / 97

Outcome results

Primary

Responder Rate Based on the Blinded Evaluator's Live Assessment of the Galderma Cheek Wrinkles Scale (GCWS) at Rest at Month 12

Responder rate was defined as the percentage of participants with at least a 1-grade improvement from baseline on the GCWS, on both sides of the face, concurrently. GCWS is a validated 5-point scale used to assess the severity of cheek wrinkles: 0 (none \[no lines or wrinkles\]), 1 (mild \[only few superficial lines\]), 2 (moderate \[many superficial lines or a few shallow wrinkles\]), 3 (severe \[many shallow wrinkles or a few moderate depth wrinkles\]) and 4 (very severe \[many moderate wrinkles or at least one depth wrinkle with or without redundant folds\]). Higher score means more severe (worse) wrinkles. The participant was to have a relaxed face during the assessment.

Time frame: At Month 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure.

ArmMeasureValue (NUMBER)
Control Group: No-treatmentResponder Rate Based on the Blinded Evaluator's Live Assessment of the Galderma Cheek Wrinkles Scale (GCWS) at Rest at Month 1226.1 percentage of participants
Treatment Group: Sculptra AestheticResponder Rate Based on the Blinded Evaluator's Live Assessment of the Galderma Cheek Wrinkles Scale (GCWS) at Rest at Month 1271.6 percentage of participants
p-value: <0.0001Fisher Exact
Secondary

Change From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total Scores

The participant assessed satisfaction using the 5 questions on the FACE-Q: Satisfaction with Cheeks Appearance questionnaire measured on a 4-point scale where 1=very dissatisfied, 2=somewhat dissatisfied, 3=somewhat satisfied, and 4=very satisfied. The responses to the items were converted to a 100-point Rasch transformed total score with 0 (worst) to 100 (best). Higher scores indicate higher satisfaction. A negative change from baseline indicates less improvement.

Time frame: Treatment group: Baseline, Months 1, 2, 3, 7, 9 and 12; Control group: Baseline, Months 7, 9 and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure and number analyzed signifies those participants who were evaluable at the specified timepoints.

ArmMeasureGroupValue (MEAN)Dispersion
Control Group: No-treatmentChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 7-4.1 score on a scaleStandard Deviation 20.34
Control Group: No-treatmentChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 12-3.6 score on a scaleStandard Deviation 21.76
Control Group: No-treatmentChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 9-3.6 score on a scaleStandard Deviation 21.36
Treatment Group: Sculptra AestheticChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 338.6 score on a scaleStandard Deviation 26.51
Treatment Group: Sculptra AestheticChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 937.9 score on a scaleStandard Deviation 26.63
Treatment Group: Sculptra AestheticChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 738.6 score on a scaleStandard Deviation 26.3
Treatment Group: Sculptra AestheticChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 1240.0 score on a scaleStandard Deviation 29.07
Treatment Group: Sculptra AestheticChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 121.3 score on a scaleStandard Deviation 24.25
Treatment Group: Sculptra AestheticChange From Baseline in Satisfaction With Cheeks FACE-Q™ Questionnaire Rasch-transformed Total ScoresAt Month 231.6 score on a scaleStandard Deviation 28.45
Secondary

Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs

An adverse event (AE) was any untoward medical occurrence in a clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. TEAEs were defined as AEs with a start date on or after the first dose of investigational product or a start date before the date of the first dose of investigational product that increased in severity or after the date of the first dose. A SAE was any untoward medical occurrence (whether considered to be related to investigational product or not) that at any dose: resulted in death, was life-threatening, required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, was a congenital abnormality/birth defect, and was an important medical event. TEAEs included both serious and non-serious TEAEs.

Time frame: From start of study drug administration up to end of the study (up to Month 12)

Population: Safety population (SP) included all participants who were treated with Sculptra Aesthetic or randomized to the no treatment control group.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentNumber of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEsNon-serious AE3 Participants
Control Group: No-treatmentNumber of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEsSerious AE0 Participants
Treatment Group: Sculptra AestheticNumber of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEsNon-serious AE43 Participants
Treatment Group: Sculptra AestheticNumber of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEsSerious AE3 Participants
Secondary

Percentage of Participants With At Least Improved on the GAIS Based on the Investigator Live Assessment

GAIS responder rates are based on independent assessments by the investigator. Responder rate was defined as the percentage of participants with at least Improved when compared to baseline before first treatment. The 7-graded GAIS was used by the investigator to live assess the aesthetic improvement of the cheek wrinkles by responding to the question: How would you describe the aesthetic improvement today compared to the photograph taken before treatment? by using the respective categorical scale as follows; Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure and number analyzed signifies those participants who were evaluable at the specified timepoints.

ArmMeasureGroupValue (NUMBER)
Control Group: No-treatmentPercentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentMonth 76.8 percentage of participants
Control Group: No-treatmentPercentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentMonth 94.4 percentage of participants
Control Group: No-treatmentPercentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentMonth 124.3 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentMonth 992.9 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentMonth 796.1 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With At Least Improved on the GAIS Based on the Investigator Live AssessmentMonth 1294.3 percentage of participants
Secondary

Percentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live Assessment

GAIS responder rates are based on independent assessments by the participant. Responder rate was defined as the percentage of participants with at least Improved when compared to baseline before first treatment. The 7-graded GAIS was used by the participant to live assess the aesthetic improvement of the cheek wrinkles by responding to the question: How would you describe the aesthetic improvement today compared to the photograph taken before treatment? by using the respective categorical scale as follows; Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure and number analyzed signifies those participants who were evaluable at the specified timepoints.

ArmMeasureGroupValue (NUMBER)
Control Group: No-treatmentPercentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentMonth 77.0 percentage of participants
Control Group: No-treatmentPercentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentMonth 96.8 percentage of participants
Control Group: No-treatmentPercentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentMonth 126.5 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentMonth 793.5 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentMonth 989.4 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With At Least Improved on the Global Aesthetic Improvement Scale (GAIS) Based on the Participants Live AssessmentMonth 1292.0 percentage of participants
Secondary

Percentage of Participants With Improvement Rate Based on the Independent Photographic Reviewer's Assessment

Improvement rate based on the Independent Photographic Reviewer's assessment using random pairings of baseline and Month 12 photographs was done. An improved subject is defined as a subject for whom the Independent Photographic Reviewer identified the month 12 photograph in the pair as post-treatment.

Time frame: At Month 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure and number analyzed signifies those participants who were evaluable at the specified timepoints.

ArmMeasureGroupValue (NUMBER)
Control Group: No-treatmentPercentage of Participants With Improvement Rate Based on the Independent Photographic Reviewer's AssessmentLeft Cheek29.5 percentage of participants
Control Group: No-treatmentPercentage of Participants With Improvement Rate Based on the Independent Photographic Reviewer's AssessmentRight Cheek34.1 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With Improvement Rate Based on the Independent Photographic Reviewer's AssessmentLeft Cheek53.6 percentage of participants
Treatment Group: Sculptra AestheticPercentage of Participants With Improvement Rate Based on the Independent Photographic Reviewer's AssessmentRight Cheek57.1 percentage of participants
Secondary

Responder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS at Rest at Months 7 and 9

Responder rate was defined as the percentage of participants with at least a 1-grade improvement from baseline on the GCWS, on both sides of the face, concurrently. GCWS is a validated 5-point scale used to assess the severity of cheek wrinkles: 0 (none \[no lines or wrinkles\]), 1 (mild \[only few superficial lines\]), 2 (moderate \[many superficial lines or a few shallow wrinkles\]), 3 (severe \[many shallow wrinkles or a few moderate depth wrinkles\]) and 4 (very severe \[many moderate wrinkles or at least one depth wrinkle with or without redundant folds\]). Higher score means more severe (worse) wrinkles. The participant was to have a relaxed face during the assessment.

Time frame: At Months 7 and 9

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure and number analyzed signifies those participants who were evaluable at the specified timepoints.

ArmMeasureGroupValue (NUMBER)
Control Group: No-treatmentResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS at Rest at Months 7 and 9Month 931.1 percentage of participants
Control Group: No-treatmentResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS at Rest at Months 7 and 9Month 738.6 percentage of participants
Treatment Group: Sculptra AestheticResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS at Rest at Months 7 and 9Month 970.6 percentage of participants
Treatment Group: Sculptra AestheticResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS at Rest at Months 7 and 9Month 766.2 percentage of participants
p-value: =0.0043Fisher Exact
p-value: <0.0001Fisher Exact
Secondary

Responder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12

Responder rate was defined as the percentage of participants with at least a 1-grade improvement from baseline on the GCWS, on both sides of the face, concurrently. GCWS is a validated 5-point scale used to assess the severity of cheek wrinkles: 0 (none \[no lines or wrinkles\]), 1 (mild \[only few superficial lines\]), 2 (moderate \[many superficial lines or a few shallow wrinkles\]), 3 (severe \[many shallow wrinkles or a few moderate depth wrinkles\]) and 4 (very severe \[many moderate wrinkles or at least one depth wrinkle with or without redundant folds\]). Higher score means more severe (worse) wrinkles. The participant was to have a closed maximum smile during the assessment.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, Overall Number of Participants Analyzed signifies those participants who were evaluable for this outcome measure and number analyzed signifies those participants who were evaluable at the specified timepoints.

ArmMeasureGroupValue (NUMBER)
Control Group: No-treatmentResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12Month 727.3 percentage of participants
Control Group: No-treatmentResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12Month 922.2 percentage of participants
Control Group: No-treatmentResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12Month 1228.3 percentage of participants
Treatment Group: Sculptra AestheticResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12Month 1270.5 percentage of participants
Treatment Group: Sculptra AestheticResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12Month 767.5 percentage of participants
Treatment Group: Sculptra AestheticResponder Rate Based on the Blinded Evaluator's Live Assessment of the GCWS Dynamic at Months 7, 9 and 12Month 964.7 percentage of participants
Secondary

Satisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 7Excellent17 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 7Very Good23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 7Good13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 7Satisfactory19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 7Not Satisfied5 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 9Excellent19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 9Very Good28 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 9Good18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 9Satisfactory13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 9Not Satisfied7 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 12Excellent20 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 12Very Good21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 12Good27 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 12Satisfactory13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?At Month 12Not Satisfied7 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Improve Your Self-confidence?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 7Good16 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 7Excellent14 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 7Very good24 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 7Satisfactory18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 7Not Satisfied5 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 9Excellent18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 9Very good25 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 9Good25 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 9Satisfactory9 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 9Not Satisfied8 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 12Excellent20 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 12Very good21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 12Good30 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 12Satisfactory10 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Self-confidence?At Month 12Not Satisfied7 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 7Excellent18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 7Very good24 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 7Good17 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 7Satisfactory13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 7Not Satisfied5 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 9Excellent25 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 9Very good26 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 9Good16 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 9Satisfactory11 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 9Not Satisfied7 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 12Excellent21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 12Very good25 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 12Good26 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 12Satisfactory11 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Firmness?At Month 12Not Satisfied5 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 12Satisfactory10 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 7Excellent21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 7Very good19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 7Good13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 7Satisfactory19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 7Not Satisfied5 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 9Excellent23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 9Very good26 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 9Good13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 9Satisfactory17 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 9Not Satisfied6 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 12Excellent22 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 12Very good23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 12Good24 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Radiance?At Month 12Not Satisfied8 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 7Excellent15 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 7Very good23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 7Good20 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 7Satisfactory7 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 7Not Satisfied12 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 9Excellent23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 9Very good19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 9Good24 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 9Satisfactory11 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 9Not Satisfied8 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 12Excellent20 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 12Very good16 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 12Good32 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 12Satisfactory9 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Improve Your Skin Sagging?At Month 12Not Satisfied11 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 7Excellent18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 7Very Good20 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 7Good17 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 7Satisfactory18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 7Not Satisfied4 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 9Excellent18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 9Very Good28 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 9Good22 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 9Satisfactory10 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 9Not Satisfied7 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 12Excellent21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 12Very Good23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 12Good27 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 12Satisfactory11 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Feel Better About Yourself?At Month 12Not Satisfied6 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 7Excellent19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 7Very good19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 7Good16 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 7Satisfactory18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 7Not Satisfied5 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 9Excellent17 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 9Very good26 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 9Good21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 9Satisfactory15 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 9Not Satisfied6 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 12Excellent19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 12Very good21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 12Good28 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 12Satisfactory13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?At Month 12Not Satisfied7 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 7Excellent18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 7Very good19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 7Good12 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 7Satisfactory18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 7Not Satisfied10 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 9Excellent21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 9Very good22 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 9Good22 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 9Satisfactory14 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 9Not Satisfied6 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 12Excellent19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 12Very good20 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 12Good25 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 12Satisfactory17 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?At Month 12Not Satisfied7 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Make You Look Younger?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 7Excellent13 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 7Very good24 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 7Good15 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 7Satisfactory19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 7Not satisfied6 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 9Excellent19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 9Very good26 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 9Good18 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 9Satisfactory15 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 9Not satisfied7 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 12Excellent15 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 12Very good29 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 12Good24 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 12Satisfactory11 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make You Look Younger?At Month 12Not satisfied9 Participants
Secondary

Satisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?

A 5-point subject satisfaction questionnaire with the following responses: Excellent, Very good, Good, Satisfactory, Not satisfied.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 7Good19 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 7Excellent16 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 7Very good23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 7Satisfactory12 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 7Not satisfied7 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 9Excellent23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 9Very good26 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 9Good16 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 9Satisfactory14 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 9Not satisfied6 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 12Excellent23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 12Very good21 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 12Good23 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 12Satisfactory14 Participants
Control Group: No-treatmentSatisfaction With Treatment: Does the Treatment Make Your Skin Look More Refreshed?At Month 12Not satisfied7 Participants
Secondary

Subject Satisfaction: Would You do the Treatment Again?

A subject satisfaction question with responses Yes or No.

Time frame: At Month 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluated for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSubject Satisfaction: Would You do the Treatment Again?Yes76 Participants
Control Group: No-treatmentSubject Satisfaction: Would You do the Treatment Again?No12 Participants
Secondary

Subject Satisfaction: Would You Recommend the Treatment to a Friend?

A subject satisfaction question with responses Yes or No.

Time frame: At Month 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSubject Satisfaction: Would You Recommend the Treatment to a Friend?Yes78 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Recommend the Treatment to a Friend?No10 Participants
Secondary

Subject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?

A 5-point subject satisfaction questionnaire with the following responses: Strongly agree, Agree, Neither agree or Disagree, Disagree, Strongly disagree.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 7Strongly agree47 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 7Agree25 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 7Neither Agree or Disagree4 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 7Disagree1 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 7Strongly Disagree0 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 9Strongly agree48 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 9Agree25 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 9Neither Agree or Disagree11 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 9Disagree0 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 9Strongly Disagree1 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 12Strongly agree47 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 12Agree30 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 12Neither Agree or Disagree7 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 12Disagree2 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say That the Treatment Results Are Natural Looking?At Month 12Strongly Disagree2 Participants
Secondary

Subject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?

A 5-point subject satisfaction questionnaire with the following responses: Strongly agree, Agree, Neither agree or Disagree, Disagree, Strongly disagree.

Time frame: At Months 7, 9, and 12

Population: ITT population included all participants who were randomized based on the treatment they were randomized to. Here, overall number of participants analyzed refer to the participants evaluable for this outcome measure and number analyzed refer to participants evaluable for this outcome at given timepoints. The data was planned to be collected and analyzed for treatment group only.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 7Neither agree or Disagree11 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 7Disagree2 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 7Strongly disagree1 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 7Strongly agree36 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 7Agree27 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 9Strongly agree41 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 9Agree27 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 9Neither agree or Disagree13 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 9Disagree1 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 9Strongly disagree3 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 12Strongly agree41 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 12Agree31 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 12Neither agree or Disagree12 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 12Disagree2 Participants
Control Group: No-treatmentSubject Satisfaction: Would You Say the Subtle Changes Over Time Was Worth It?At Month 12Strongly disagree2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026